An epigenetic mechanism for capecitabine resistance in mesothelioma
about
Cancer drug resistance: redox resetting renders a wayIdentifying therapeutic targets in gastric cancer: the current status and future directionCancer stem cells and chemoresistance: The smartest survives the raidTranslational advances in pleural malignancies.Photochemical activation of drugs for the treatment of therapy-resistant cancers.Thymidine phosphorylase: A potential new target for treating cardiovascular disease.
P2860
An epigenetic mechanism for capecitabine resistance in mesothelioma
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An epigenetic mechanism for capecitabine resistance in mesothelioma
@ast
An epigenetic mechanism for capecitabine resistance in mesothelioma
@en
type
label
An epigenetic mechanism for capecitabine resistance in mesothelioma
@ast
An epigenetic mechanism for capecitabine resistance in mesothelioma
@en
prefLabel
An epigenetic mechanism for capecitabine resistance in mesothelioma
@ast
An epigenetic mechanism for capecitabine resistance in mesothelioma
@en
P2093
P2860
P1476
An epigenetic mechanism for capecitabine resistance in mesothelioma
@en
P2093
G A Otterson
K V Kosuri
M A Villalona-Calero
P2860
P304
P356
10.1016/J.BBRC.2009.12.095
P407
P577
2009-12-24T00:00:00Z